Yayın:
Development of nano-sized ketoprofen lysine incorporated Eudragit® S100 nanomedicine by double emulsion solvent evaporation and in vitro characterization

dc.contributor.authorÖZTÜRK, AHMET ALPER
dc.contributor.authorÇinar, Nur İlge
dc.contributor.authorAKYIL, EVRİM
dc.contributor.orcid0000-0001-9596-0538
dc.contributor.orcid0000-0002-7979-0089
dc.date.accessioned2025-11-13T10:15:13Z
dc.date.issued2019-01-01
dc.identifier.doihttps://doi.org/10.56499/jppres18.447_7.1.47
dc.identifier.endpage58
dc.identifier.issn0719-4250
dc.identifier.issue1
dc.identifier.openalexW3194763038
dc.identifier.startpage47
dc.identifier.urihttps://hdl.handle.net/11421/3589
dc.identifier.urihttps://doi.org/10.56499/jppres18.447_7.1.47
dc.identifier.volume7
dc.language.isoen
dc.relation.ispartofJournal of Pharmacy & Pharmacognosy Research
dc.rightsopenAccess
dc.subjectKetoprofen
dc.subjectNanomedicine
dc.subjectEmulsion
dc.subjectEvaporation
dc.subjectNano-
dc.subjectChemistry
dc.subjectSolvent
dc.subjectMaterials science
dc.subjectNuclear chemistry
dc.subjectOrganic chemistry
dc.subjectNanoparticle
dc.subjectChromatography
dc.subjectNanotechnology
dc.subjectPhysics
dc.titleDevelopment of nano-sized ketoprofen lysine incorporated Eudragit® S100 nanomedicine by double emulsion solvent evaporation and in vitro characterization
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5079685563
local.authorid.openalexA5091291474
local.authorid.openalexA5039882624

Dosyalar

Koleksiyonlar